While Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) have appreciated 38 percent since the favorable U.S. Fanapt IP ruling on August 25, Jefferies’ Matthew J. Andrews believes that there could be potential for long-term upside to the …
Mr. Richard L. Gulino is Senior Vice President, General Counsel, Secretary of Vanda Pharmaceuticals Inc. Prior to joining us, Mr. Gulino was Vice President and General Counsel of Ameritox, Ltd., a clinical drug testing laboratory, from June …
WASHINGTON (AP) _ Vanda Pharmaceuticals Inc. (VNDA) on Wednesday reported a loss of $604,000 in its fourth quarter. The Washington-based company said it had a loss of 1 cent per share. Earnings, adjusted for amortization …
After a surprise FDA approval for Fanapt (iloperidone) for second-line schizophrenia therapy in May 2009, Vanda Pharmaceuticals (NASDAQ:VNDA) stock rose nearly 800% and has traded in the $12-$15 range since then until mid …
Some of the biggest gainers among Manufacturing stocks include: Newlink Genetics Corp (NLNK): NLNK stock is up ... Article printed from InvestorPlace Media, http://investorplace.com/2015/10/biggest-movers-in-manufacturing-stocks
VNDA closed Monday's trading at $15.40 ... VTVT closed Monday's trading at $3.26, down 4.68%. In after-hours, the stock tumbled 63.80% to $1.18.
Vanda Pharmaceuticals (VNDA) was a big mover last session, as its shares rose over 8% on the day. The upside was driven by the company’s second-quarter financial result announcement. This also led to far more shares changing …
On April 18, 2013, Vanda Pharmaceuticals (NASDAQ:VNDA) stock reached a 52-week high. Why? Until recently, many investors had given up on the Washington, DC-based pharmaceutical company. The reason was Fanapt (iloperidone), …
VNDA stock, which was up 14% today on strong volume of 5.7 million shares, has soared more than 65% since mid-October. As of this writing, Ethan Roberts did not hold any positions in the aforementioned securities.